<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The CDX2 (caudal-related homeobox gene 2) and PITX1 (pituitary homeobox 1) genes have essential roles in human development </plain></SENT>
<SENT sid="1" pm="."><plain>Forced expression of Cdx2 alone in the murine stomach results in gastric <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (IM) </plain></SENT>
<SENT sid="2" pm="."><plain>This study was undertaken to investigate the expression pattern of these critical morphogenesis genes in the Barrett's multistage <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> model </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: CDX2 and PITX1 <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> (<z:chebi fb="2" ids="33699">mRNA</z:chebi>) expression levels, relative to the control gene beta-actin, were measured by reverse transcription-polymerase chain reaction in specimens of Barrett's IM (n = 21), <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 18), <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 20), and matching <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophagus tissues (n = 39) collected from 19 patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and 20 patients with esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>CDX2 protein expression was assessed by immunohistochemistry in specimens of <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophagus (n = 13), IM (n = 10), <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 8,) and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 5) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The median relative CDX2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression was approximately 200 times higher in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> tissues (0.83) than in matching <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophagus (0.004) in the patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (P &lt; .001) </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues (0.49) was also higher than in matching <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophagus specimens (0.009, P &lt; .001) </plain></SENT>
<SENT sid="7" pm="."><plain>There was no significant difference between the <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>There was no CDX2 protein expression in <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophagus, but moderate to strong protein expression was seen in <z:hpo ids='HP_0000001'>all</z:hpo> Barrett's tissues and in a majority of the <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cells </plain></SENT>
<SENT sid="9" pm="."><plain>Relative median PITX1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression was decreased in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (8.02 for <z:hpo ids='HP_0000001'>all</z:hpo> specimens), compared with <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus specimens (47.46 for <z:hpo ids='HP_0000001'>all</z:hpo> specimens, P &lt; .001), and was further reduced in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> specimens (2.21), compared with either <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> or <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus (both P &lt; .001) </plain></SENT>
<SENT sid="10" pm="."><plain>Wilcoxon testwas used for <z:hpo ids='HP_0000001'>all</z:hpo> P values shown </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: CDX2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> and CDX2 protein expression are upregulated in Barrett's IM tissues, compared with <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophagus, and remain elevated in <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissues </plain></SENT>
<SENT sid="12" pm="."><plain>In contrast, PITX1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression is decreased in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, compared with matching <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophagus specimens, and is further decreased in Barrett's-associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>These descriptive findings suggest a possible role for these genes in the Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence </plain></SENT>
</text></document>